期刊文献+

常规分割三维适形放射治疗局部晚期胰腺癌临床观察 被引量:2

原文传递
导出
摘要 目的探讨常规分割三维适形放射治疗局部晚期胰腺癌的临床效果。方法对26例局部晚期胰腺癌患者进行常规分割三维适形放射治疗。结合剂量-体积直方图选择最佳治疗方案,应用5~7个共面或非共面野照射,90%等剂量线包绕PTV,常规分割,每周5次,每次2 GY,总剂量62~74 GY。结果肿瘤全消者占7.7%(2/26),肿瘤部分消失者占53.8%(14/26),临床受益反应率为46.2%,14例黄疸患者中,12例黄疸完全消退,1年、2年生存率分别为57%、19%,急性放射反应不重。结论常规分割三维适形放射治疗能使晚期胰腺癌患者症状减轻,提高生活质量和延长生存期,是一种合理的治疗模式。
出处 《中国基层医药》 CAS 2007年第11期1837-1838,共2页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献8

二级参考文献37

  • 1李艳丽,苏学峰,李南征,柴海燕,王鹤皋.常规分割立体定向适形放射治疗晚期胰腺癌28例临床观察[J].中国肿瘤临床,2004,31(13):747-748. 被引量:3
  • 2Brenner DJ, Hall EJ. Stereotactic radiotherapy of intracranial tumors: an ideal candidate for accelerated treatment. Int J Radiat Oncol Biol Phys, 1994, 28:1039-1041.
  • 3Larson DA, Flickinger JC, Loeffler JS. The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys, 1993,25:557-561.
  • 4Brenner DJ, Martel MK, Hall EJ. Fractionated regimes for stereotactic radiotherapy of recurrent tumor in the brain. Int J Radiat Oncol Biol Phys, 1991, 21:819-824.
  • 5Orton CG,Cohen L. A unified approach to dose-effect relationships in radiotherapy I: modified TDF and linear quadratic equations. Int J Radiat Oncol Biol Phys, 1988,14:549-556.
  • 6Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy. Sem Radiat Oncol, 1992, 2:16.
  • 7Ten Hakan RK, Frass BA, Lichter AS, et al. A brain tumor dose eacalation protocal based on effective dose equivalence to prior experience. Int J Radiat Oncol Biol Phys, 1998,42:137-141.
  • 8余同行,肿瘤预后学,1995年,503页
  • 9胡逸民,肿瘤放射治疗学,1994年,214页
  • 10贾振庚,中华外科杂志,1993年,32卷,163页

共引文献69

同被引文献18

  • 1卢凯华,仇金荣,黄普文,穆庆霞,王榕生,朱陵君,束永前,刘宝瑞.吉西他滨联合铂类药物治疗晚期胰腺癌的疗效观察[J].中国基层医药,2004,11(10):1153-1154. 被引量:2
  • 2Mohiuddin M,Rosato F,Darbot D,et al.Long-term results of combined modality treatment with I-125 inplantation for carcinoma of pancreas.Int J Radiat Oncol Bio Phys,1992,23(2):305-311.
  • 3Cooperman AM.Pancreatic cancer:the bigger picture.Surg Clin North Am,2001,81 (3):557-574.
  • 4Sobin LH,Fleming ID.TNM Classification of Malignant Tumors,fifth edition(1997).Union Internationale Contre Ie Cancer and the American Joint Committee on Cancer.Cancer,1997,80(9):1803-1804.
  • 5Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial.J Clin Onco1,1997,15(6):2403-2413.
  • 6Wilkowski R,Thoma M,Bruns C,et al.Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.JOP,2006,10(7):349-360.
  • 7Harris J,Bruckner H.Adjuvant and Neoadjuvant Therapies of Pancreatic Cancer.Int J Gastrointest Cancer,2001,29(1):1-8.
  • 8Ling CC.Permanent implants using Au-198,Pd-103 and I-125:radiobiological considerations based on the linear quadratic model.Int J Radiat Oncol Biol Phys,1992,23(1):81-87.
  • 9Willett CG,Safran H,Abrams RA,et al.Clinical research in pancreatic cancer:the Radiation Therapy Oncology Group trials.Int J Radiat Oncol Biol Phys,2003,56(4 Suppl):S31 -37.
  • 10殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学.4版.北京:中国协和医科大学出版社,2007:842.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部